Statistics
Publications
3
Citations
78
H-Index
3
Active since
2011
Affiliations
University School(Current)
Matthew Mirsky is an author at University School specializing in dual immune checkpoint inhibition, melanoma neoadjuvant therapy, and neoadjuvant immunotherapy.
Publications per year
2011–2024
3
3
Leslie J. Marshall, L. David Moore, Matthew Mirsky et al. · Journal of General Virology · 2011 · 34 citations · Full text
Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
Ankit Mangla, Chanmi Lee, Matthew Mirsky et al. · JAMA Oncology · 2024 · 17 citations · Full text
1–3 of 3